Affiliation:
1. Pharmacology Unit, Faculty of Pharmacy, AIMST University, Semeling, Bedong 08100, Kedah, Malaysia
Abstract
Neurovascular dysfunction leads to the second most common type of dementia, i.e., vascular dementia (VaD). Toxic metals, such as aluminium, increase the risk of neurovascular dysfunction-associated VaD. Hence, we hypothesized that a natural antioxidant derived from palm oil, i.e., tocotrienol-rich fraction (TRF), can attenuate the aluminium chloride (AlCl3)-induced VaD in rats. Rats were induced with AlCl3 (150 mg/kg) intraperitoneally for seven days followed by TRF treatment for twenty-one days. The elevated plus maze test was performed for memory assessment. Serum nitrite and plasma myeloperoxidase (MPO) levels were measured as biomarkers for endothelial dysfunction and small vessel disease determination. Thiobarbituric acid reactive substance (TBARS) was determined as brain oxidative stress marker. Platelet-derived growth factor-C (PDGF-C) expression in the hippocampus was identified using immunohistochemistry for detecting the neovascularisation process. AlCl3 showed a significant decrease in memory and serum nitrite levels, while MPO and TBARS levels were increased; moreover, PDGF-C was not expressed in the hippocampus. However, TRF treatment significantly improved memory, increased serum nitrite, decreased MPO and TBARS, and expressed PDGF-C in hippocampus. Thus, the results imply that TRF reduces brain oxidative stress, improves endothelial function, facilitates hippocampus PDGF-C expression for neovascularisation process, protects neurons, and improves memory in neurovascular dysfunction-associated VaD rats.
Funder
AIMST University Internal Research
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference68 articles.
1. Dementia Risk and Prevention by Targeting Modifiable Vascular Risk Factors;Tariq;J. Neurochem.,2018
2. Shabir, O., Berwick, J., and Francis, S.E. (2018). Neurovascular Dysfunction in Vascular Dementia, Alzheimer’s and Atherosclerosis. BMC Neurosci., 19.
3. Epidemiology of Vascular Dementia;Wolters;Arterioscler. Thromb. Vasc. Biol.,2019
4. Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective;Kuang;Aging Dis.,2021
5. Endothelial Dysfunction in the Brain;Sashindranath;Stroke,2021